What is TransMedics Group, Inc.'s gain/loss on asset sales?

TransMedics Group, Inc. (TMDX) reported gain/loss on asset sales of -$80K in Q1 2025.

How has TransMedics Group, Inc.'s gain/loss on asset sales changed year-over-year?

TransMedics Group, Inc.'s gain/loss on asset sales decreased by 1782.4% year-over-year, from -$4.25K to -$80K.

What does gain/loss on asset sales mean?

Gains or losses on asset disposals removed from operating cash flow — the cash impact is captured in investing activities.

TransMedics Group, Inc. TMDX Gain/Loss on Asset Sales

Gain/Loss on Asset Sales at other companies

MYR GroupMYRG

$922K-16.3%

SSR MiningSSRM

-$3.24M—

NNN REITNNN

$12.19M+220%

RepligenRGEN

-$13.76M—

UnifirstUNF

-$233K-3,983%

Sensata TechnologiesST

$0+100%

Other financials

Income statement

See full

Revenue$173.9M+21.2%

Gross profit$101.2M+14.7%

Operating income$13.3M-51.5%

Net income$7.3M-71.5%

EPS (diluted)$0.20-71.4%

Balance sheet

See full

Cash & equivalents$461.7M+48.9%

Total debt$409.9M+505%

Total equity$494.0M+85.5%

Total assets$1.4B+71.3%

Cash flow

See full

Operating cash flow$24.5M+959%

CapEx$36.7M+35.6%

Free cash flow-$12.1M+59.4%

Valuation

See full

Market cap$2.55B+50.6%

Enterprise value$2.5B+66.0%

P/E14.8×-19.8×

P/S4×+0.5×

Profitability

See full

Gross margin59.1%-0.4pp

Operating margin14.9%+4.1pp

Net margin27%+17.0pp

FCF margin23.8%—

Returns & leverage

See full

Return on equity45.2%+22.2pp

Debt / equity0.8×+0.6×

Current ratio6.7×-2.4×

Where this comes from

Reported directly by TransMedics Group, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnDispositionOfAssets1.

The official record: TransMedics Group, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about TransMedics Group, Inc.'s gain/loss on asset sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TransMedics Group, Inc.'s gain/loss on asset sales?: TransMedics Group, Inc. (TMDX) reported gain/loss on asset sales of -$80K in Q1 2025.
How has TransMedics Group, Inc.'s gain/loss on asset sales changed year-over-year?: TransMedics Group, Inc.'s gain/loss on asset sales decreased by 1782.4% year-over-year, from -$4.25K to -$80K.
What does gain/loss on asset sales mean?: Gains or losses on asset disposals removed from operating cash flow — the cash impact is captured in investing activities.